NBIX
Neurocrine Biosciences Inc
Price:  
133.62 
USD
Volume:  
770,692.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

NBIX Probability of Bankruptcy

The Probability of Bankruptcy of Neurocrine Biosciences Inc (NBIX) is 3.92% . This number represents the probability that NBIX will face financial distress in the next 24 months given its current fundamentals and market conditions.

Multiple factors are taken into account when calculating NBIX's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.

NBIX - ESG ratings

ESG ratings are directly linked to the cost of capital and NBIX's ability to raise funding, both of which can significantly affect the probability of Neurocrine Biosciences Inc going bankrupt.

ESG Score 65.96
Environment Score 67.93
Social Score 91.57
Governance Score 38.37
Returns
Historical Returns (5 day) -0.65%
Historical Returns (MTD) -0.62%
Historical Returns (YTD) 2.13%
Historical Returns (13 week) -4.32%
Historical Returns (26 week) 10.89%
Historical Returns (52 week) 37.53%
Efficiency
Asset Turnover 0.65
Receiveable Turnover 4.71
Gross Margin 98.54%
Operating Margin 19.27%
Pretax Margin 6.70%
Net Margin 8.42%
Return on Asset (ROA) 12.14
Return on Equity (ROE) 17.45
Return on Investments (ROI) 16.24
Price Metrics
Market Cap (M) 13,447.52
Enterprise Value (M)
52 Week High 148.37
52 Week Low 93.02
Beta 0.57
Average Volume (10 day) 0.77
Average Volume (3 month) 0.84
Price / Earnings (P/E) 36.59
Price / Sales (P/S) 6.83
Earnings
EPS 3.64
Revenue CAGR (5 year) 33.13%
Risk
Current Ratio 2.52
Quick Ratio 2.47